Drug - Zyclara (imiquimod) Cream, 2.5%, 3.75% [Graceway Pharmaceuticals]
Therapeutic Area - Dermatology (Actinic Keratosis)
Patient has a diagnosis of Actinic Keratosis or external genital warts.
FDA approved indication
Zyclara Cream is indicated for the topical treatment of clinically typical, visible or palpable actinic keratosis (AK) of the full face or balding scalp in immunocompetent adults and for the treatment of external genital and perianal warts (EGW)/condyloma acuminata in patients 12 years or older.
Dosing and administration
Once daily to the skin of the affected area (either the entire face or balding scalp) for two 2-week treatment cycles separated by a 2-week no-treatment period. Dosing recommendation is a 2-cycle treatment course.
*List price as supplied $24.42/single use packet.
Imiquimod is also available as a 5% cream, which is available as a brand product, Aldara, and a generic product.
MHCP Provider Call Center 651-431-2700 or 800-366-5411